STAT

AUGUST 21, 2024

For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.

363

363

PharmaVoice

AUGUST 21, 2024

The Supreme Court case added another layer of uncertainty on the regulatory front and opened up the Inflation Reduction Act to more legal attacks.

130

130

STAT

AUGUST 21, 2024

A year ago, after much fanfare and controversy , the Food and Drug Administration approved Eisai and Biogen’s lecanemab, an anti-amyloid drug that moderately slowed cognitive decline in patients with Alzheimer’s disease. But doctors have been hesitant to prescribe the drug and its pharmacological cousin, Eli Lilly’s donanemab, for people with Down syndrome because of a lack of safety data.

347

347

Express Pharma

AUGUST 21, 2024

The popularity of glucagon-like peptide-1 receptor (GLP-1R) drugs has exploded in recent years due to their ability to effectively treat metabolic-related disorders such as obesity and type 2 diabetes. As obesity rates rise and trust in GLP-1R products grows, sales for drugs targeting this receptor are forecast to increase fourfold to an estimated $142 billion by 2030.

Diabetes 126

Diabetes 126

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

AUGUST 21, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is now upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. So what better way to make the time fly than to keep busy.

Diabetes 267

Diabetes Immunization Immunity 267

pharmaphorum

AUGUST 21, 2024

Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.

117

117

Pharma Times

AUGUST 21, 2024

The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods

129

129

Express Pharma

AUGUST 21, 2024

Strides Alathur, a wholly owned subsidiary of Strides Pharma Science has received an Establishment Inspection Report (EIR) from the U S Food and Drug Administration (USFDA) for its formulations facility at Alathur, Chennai thereby successfully concluding the Good Manufacturing Practices (GMP) inspection conducted between April 1-5, 2024. USFDA has determined that the inspection classification of this facility is “Voluntary Action Indicated” (VAI).

110

110

BioPharma Dive

AUGUST 21, 2024

Backed by $300 million from investors that include Viking Global Investors and Sequoia Capital, GondolaBio will inherit several BridgeBio drug programs.

113

113

Express Pharma

AUGUST 21, 2024

A major fire occurred after a reactor explosion ripped through Escientia Life Sciences’ factory in Anakapalle on Wednesday, August 21, 2024. Latest reports suggest that 17 people have died and approximately 33 are injured. The death toll may rise as several people are still stuck underneath the rubble. The explosion and the fire occurred during the lunch break at Escientia’s factory at Atchutapuram Special Economic Zone, a pharmaceutical company hub.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

AUGUST 21, 2024

Debate over the safety of GLP-1 drugs resurfaces after study finds 'disproportional' risk of suicidal thinking adverse event reports with Novo Nordisk's semaglutide

107

107

Express Pharma

AUGUST 21, 2024

Indoco Remedies announced the receipt of final approval from the USFDA for an Abbreviated New Drug Application (ANDA) for Lofexidine Tablets 0.18 mg to market a generic equivalent of Lucemyra Tablets, 0.18 mg of USWM. Indoco has been granted a Competitive Generic Therapy (CGT) designation by the USFDA and being the first approved generic, is eligible for 180 days of CGT exclusivity for Lofexidine Tablets, 0.18 mg (“Product”) in the USA.

109

109

BioPharma Dive

AUGUST 21, 2024

Pharmaceuticals like the in-demand GLP-1 drugs for obesity are expected to drive increases in healthcare spending in 2025, per a new employer survey.

107

107

pharmaphorum

AUGUST 21, 2024

A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost its sales.The suit filed on behalf of Medicare Advantage coverage providers accuses the company of "funnelling hundreds of millions of dollars" to Copaxone (glatiramer acetate) patients through third-party foundations and companies.

107

107

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

AUGUST 21, 2024

Company executives had previously warned investors that a delay was likely due to issues at a facility run by third-party manufacturer.

112

112

pharmaphorum

AUGUST 21, 2024

J&J's Rybrevant/Lazcluze combination is cleared by FDA for first-line EGFR+ NSCLC, giving AstraZeneca's top-seller Tagrisso its first direct competition

106

106

Pharma Times

AUGUST 21, 2024

Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma

Hospitals 116

Hospitals 116

Pharmaceutical Technology

AUGUST 21, 2024

Amgen has announced the availability of Otezla (apremilast) in the US for paediatric patients with moderate to severe plaque psoriasis.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

AUGUST 21, 2024

GP employers in Northern Ireland have committed to engage in further negotiations on pay for practice pharmacists, the Pharmacists’ Defence Association (PDA) has confirmed. And no decision will be made on industrial action until then, the union suggested. The PDA was planning to formally ballot its practice pharmacist members in Northern Ireland after a consultation […] The post Employers to negotiate on NI practice pharmacist pay, says PDA appeared first on The Pharmacist.

80

80

Pharmaceutical Technology

AUGUST 21, 2024

The China NMPA approved AstraZeneca's Fasenra for individuals aged 12 years and older with severe eosinophilic asthma (SEA).

98

98

PharmaTech

AUGUST 21, 2024

For a preview of what's to come at the AAPS PharmSci 360 show in October, Pharmaceutical Technology® spoke with Vivek Gupta, PhD, associate dean for Graduate Education and Research, associate professor, Pharmaceutical Sciences, St. John’s University, Queens, New York, about the formulation of inhalation dosage forms.

Dosage 72

Dosage 72

Pharmaceutical Technology

AUGUST 21, 2024

The deal, valued at approximately $30m, contributes to Emergent’s financial recovery plan amid its dramatic post-Covid decline.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

AUGUST 21, 2024

Digital technologies play a crucial role in helping the pharmaceutical industry meet the changing needs of healthcare providers (HCPs) and patients. Learn how digital innovations are transforming healthcare delivery and improving patient outcomes in this comprehensive guide.

93

93

Pharmaceutical Technology

AUGUST 21, 2024

Dr Reddy's Laboratories, Aurigene Pharmaceutical and Kainomyx signed an MoU to co-develop and co-commercialise an anti-malarial drug.

87

87

World Pharma News

AUGUST 21, 2024

RNA interference (RNAi) therapeutics have garnered significant attention in clinical research due to their potential for treating various diseases, including genetic disorders, viral infections and cancer. These therapeutics can target and silence disease-causing genes with high precision, minimizing off-target effects and improving treatment outcomes.

73

73

Pharmaceutical Business Review

AUGUST 21, 2024

This asset is being assessed to treat patients with relapsed or refractory extensive-stage small-cell lung cancer (ES-SCLC) who have shown disease progression on or following treatment with platinum-based chemotherapy. The FDA’s decision is supported by data from the ongoing open-label, multi-centre Phase I ARTEMIS-001 trial, which includes more than 200 patients.

Chemotherapy 64

Chemotherapy Labelling 64

The Script

AUGUST 21, 2024

Having a good relationship with your coworkers can be game-changing. Our team at Rx relief discusses a few key best practices to adopt.

73

73

STAT

AUGUST 21, 2024

Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.

72

72

BioPharma Dive

AUGUST 21, 2024

Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.

62

62

STAT

AUGUST 21, 2024

Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population health researcher, she recalls a time four years ago when people didn’t think children could even contract the disease. Then, after accepting kids’ vulnerability to the virus, it was thought only adults could suffer from the myriad symptoms that persist or crop up post-infection, collectively known as long Covid.

72

72

Drug Patent Watch

AUGUST 21, 2024

The pharmaceutical industry has witnessed a significant surge in the availability of public disease and drug-related data, which has facilitated […] Source

Drug Development 59

Drug Development 59

Pharmaceutical Commerce

AUGUST 21, 2024

Although it still has to undergo the preclinical and clinical trial process, the DNA vaccine—which could be created in as little as six weeks—does not require the cold chain storage that mRNA jabs often demand.

Vaccines 52

Vaccines 52